title: Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
abstract: Selective amino acid restriction targets mitochondria resulting in DU145 and PC3 prostate cancer cell death. This study shows that restriction of tyrosine and phenylalanine (Tyr/Phe), glutamine (Gln), or methionine (Met) differentially modulates glucose metabolism, glycogen synthase kinase 3beta (GSK3beta), p53, and pyruvate dehydrogenase (PDH) in these two cell lines. In DU145 cells, Gln and Met restriction increase glucose consumption, but Tyr/Phe restriction does not. Addition of glucose to culture media diminishes cell death induced by Tyr/Phe-restriction. Addition of pyruvate reduces cell death due to Tyr/Phe and Gln restriction. Tyr/Phe, Gln and Met restriction increase phosphorylation of GSK3beta-Ser(9), phosphorylation of p53-Ser(15) and reduce the mitochondrial localization of PDH. Addition of glucose or pyruvate to cultures significantly reverses the alterations in GSK3beta, p53 and PDH induced by amino acid restriction. In p53-null PC3 cells, Tyr/Phe, Gln and Met restriction decreases glucose consumption, reduces phosphorylation of Akt-Ser(473), and increases phosphorylation of GSK3beta-Ser(9). Addition of pyruvate or glucose reduces death of Met-restricted cells. Addition of glucose increases phosphorylation of Akt-Ser(473) in amino acid-restricted cells reduces phosphorylation of GSK3beta-Ser(9) in Tyr/Phe and Gln restricted cells and increases phosphorylation of GSK3beta-Ser(9) in Met restricted cells. Addition of pyruvate reduces phosphorylation of GSK3beta-Ser(9) in all amino acid-restricted cells. In summary, cell death induced by specific amino acid restriction is dependent on or closely related to the modulation of glucose metabolism. GSK3beta (DU145 and PC3) and p53 (DU145) are crucial switches connecting metabolism and these signaling molecules to cell survival during amino acid restriction.
authors.affiliation: Department of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Pullman, WA 99164-6534, USA.
authors.forename: Ya-Min
authors.initials: YM
authors.lastname: Fu
authors.forename: Huimin
authors.initials: H
authors.lastname: Lin
authors.forename: Xiaoyi
authors.initials: X
authors.lastname: Liu
authors.forename: Weigang
authors.initials: W
authors.lastname: Fang
authors.forename: Gary G
authors.initials: GG
authors.lastname: Meadows
mesh_terms: D000596:Amino Acids / Q000172:deficiency* / Q000494:pharmacology; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D005455:Fluorescent Antibody Technique; D005947:Glucose / Q000378:metabolism*; D038362:Glycogen Synthase Kinase 3 / Q000378:metabolism; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D015151:Immunoblotting; D008297:Male; D008954:Models, Biological; D010766:Phosphorylation / Q000187:drug effects; D010768:Phosphoserine / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology*; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
chemical_list: D000596:Amino Acids; D011768:Pyruvate Dehydrogenase Complex; D016159:Tumor Suppressor Protein p53; D010768:Phosphoserine; C000605506:GSK3B protein, human; D000071679:Glycogen Synthase Kinase 3 beta; D051057:Proto-Oncogene Proteins c-akt; D038362:Glycogen Synthase Kinase 3; D005947:Glucose